Eocene Ltd. (EOCN) Balance Sheet

NASDAQ: EOCNAssets, liabilities, debt and equity over 4 years.

EOCN balance sheet, 2025

December 31, 2025 · U.S. dollars

$18.6M assets = $2.8M liabilities + $15.8M equity

What it owns$18.6MCash & ST investments: $18.2M (97.5%)Cash & ST investments$18.2M · 97%Other current: $471,000 (2.5%)=How it is financed$18.6MCurrent liabilities: $2.8M (15.3%)Current liabilities$2.8M · 15%Shareholders’ equity: $15.8M (84.7%)Shareholders’ equity$15.8M · 85%

Both columns are drawn to the same scale: what EOCN owns equals what it owes plus shareholders’ equity. Hover a block for its value.

EOCN financial health

Current ratio6.55
Comfortable · current assets cover current liabilities 6.55×
Equity / assets84.7%
Equity-funded · of assets funded by shareholders
Goodwill & intangibles0.0%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

EOCN balance sheet trends, 2022–2025

Eocene Ltd. balance sheet trends
MetricTrendThenLatestChange
Total assets$16.6M2022$18.6M2025+4.0%/yr
Total liabilities$3.1M2022$2.8M2025−3.2%/yr
Shareholders’ equity$13.4M2022$15.8M2025+5.5%/yr
Cash & short-term investments$13.8M2022$18.2M2025+9.6%/yr
Working capital$11.6M2022$15.8M2025+$4.2M
Current ratio4.7620226.552025+1.79

Change is the average annual growth (CAGR) or the difference between the first and latest year.

EOCN assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

EOCN liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

EOCN debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

EOCN balance sheet

Eocene Ltd. annual balance sheet
2025202420232022
Assets
Cash & short-term investments$18.2M$15.3M$12.6M$13.8M
Cash & equivalents$4.0M$4.7M$2.9M$2.0M
Short-term investments$14.2M$10.7M$9.8M$11.8M
Receivables$0$0$0$0
Inventory$0$0$0$0
Other current assets$471,000$793,000$597,000$939,000
Total current assets$18.6M$16.1M$13.2M$14.7M
Property, plant & equipment (net)$0$0$125,000$337,000
Goodwill & intangible assets$0$0$0$0
Long-term investments$0$2.1M$3.3M$1.5M
Other non-current assets$0$257,000$0$0
Total assets$18.6M$18.5M$16.6M$16.6M
Liabilities
Accounts payable$2.0M$1.3M$1.9M$2.6M
Total current liabilities$2.8M$2.2M$2.8M$3.1M
Long-term debt$0$0$0$0
Lease obligations—$0$41,000$215,000
Other long-term liabilities$0$0$0$44,000
Total liabilities$2.8M$2.2M$2.8M$3.1M
Shareholders' equity
Retained earnings (deficit)−$210.8M−$200.5M−$193.0M−$186.0M
Total shareholders' equity$15.8M$16.3M$13.9M$13.4M
Key figures
Working capital$15.8M$14.0M$10.5M$11.6M
Tangible book value$15.8M$16.3M$13.9M$13.4M
Book value per share$19.18———
Shares outstanding823K———
Current ratio6.557.424.814.76
Quick ratio6.387.064.604.46
Equity / assets84.7%88.3%83.5%81.1%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed —); data from EODHD.

EOCN financial position

At the end of fiscal 2025 (December 31, 2025), Eocene had total assets of $18.6 million (up 0.7% from a year earlier), total liabilities of $2.8 million and shareholders' equity of $15.8 million. Its current ratio was 6.55. In the latest quarter (ended June 30, 2026) total assets were $18.3 million and equity $12.7 million.

Related: EOCN income statement, EOCN cash flow statement, EOCN key metrics. See the EOCN stock overview for the latest quote and news.

EOCN balance sheet FAQ

What are Eocene's total assets?

Eocene reported total assets of $18.6 million at the end of fiscal 2025 (December 31, 2025), compared with $18.5 million a year earlier.

How much cash does Eocene have?

Eocene held $18.2 million in cash and short-term investments at the end of fiscal 2025.

What is Eocene's book value?

Eocene's shareholders' equity (book value) was $15.8 million at the end of fiscal 2025, or $19.18 per share.

What is Eocene's current ratio?

Eocene had current assets of $18.6 million and current liabilities of $2.8 million, a current ratio of 6.55 (it can cover its short-term obligations).

Biotechnology: balance sheet